Corona vaccine based on new technology tested in clinical study

Newswise — A new COVID-19 vaccine based on a different platform than current vaccines on the market has been tested in humans for the first time by researchers at Radboud University Medical Center. Administration of this vaccine in healthy study participants was well tolerated and led to a good immune response. The effectiveness of the … Read more

The Surprising Reason for the Decline in Cancer Mortality

This is Work in Progress, a newsletter by Derek Thompson about work, technology, and how to solve some of America’s biggest problems. Sign up here to get it every week. Last year, I called America a “rich death trap.” Americans are more likely to die than Europeans or other citizens of similarly rich nations at … Read more

Alzheimer’s drug lecanemab receives accelerated FDA approval amid safety concerns

CNN — The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer’s disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline. “Alzheimer’s disease immeasurably incapacitates the lives of those who suffer from it and has devastating effects on their loved ones,” Dr. … Read more

How a Cheap Liver Drug May Be the Key to Preventing COVID

Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr. F. Perry Wilson of the Yale School of Medicine. As soon as the pandemic started, the search was on for a medication that could stave off infection, or at least the worst consequences of infection. One that would be … Read more

HIV vaccine candidate induces immune response in early clinical trial

CNN — An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine given eight weeks apart can elicit immune responses against the human immunodeficiency virus. The clinical trial results, published Thursday on … Read more